Bernard Haendler is a PhD and Distinguished Science Fellow at Research & Early Development Oncology, Pharmaceuticals, Bayer AG, Berlin, Germany. Bernard Haendler’s research interests include Prostate Cancer and Androgen Signaling; Breast Cancer and Estrogen Signaling; Gene Regulation; Drug Discovery; and Resistance Mechanisms.